PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

subscribe
share






New Biomarkers, New Targets in Advanced NSCLC


Visit https://www.peervoice.com/VPK860 to view the entire programme with slides. After completing “New Biomarkers, New Targets in Advanced NSCLC”, participants will be able to: Explain the rationale for targeting TROP2 in patients with advanced non–small-cell lung cancer (NSCLC); Assess current clinical data for TROP2-directed antibody-drug conjugates (ADCs) in the management of advanced NSCLC that has progressed on current standards of care; and Formulate optimal, evidence-based treatment plans that maximise long-term outcomes for patients with advanced NSCLC.


share








 2022-08-17  20m